In Tuesday’s Wall Street session, Hims & Hers Health Inc (NYSE:HIMS) shares traded at $58.50, down -3.26% from the previous session.
HIMS stock price is now 76.66% away from the 50-day moving average and 155.38% away from the 200-day moving average. The market capitalization of the company currently stands at $12.78B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $42 to $60, Morgan Stanley Downgraded its rating from Overweight to Equal-Weight for Hims & Hers Health Inc (NYSE: HIMS). On January 10, 2025, Citigroup Downgraded its previous ‘Neutral’ rating to ‘Sell’ on the stock increasing its target price from $24 to quote $25, while ‘BTIG Research’ rates the stock as ‘Buy’
In other news, Boughton Soleil, Officer bought 4,152 shares of the company’s stock on Feb 18 ’25. The stock was bought for $251,985 at an average price of $60.69. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 18 ’25, Officer Dudum Andrew bought 175,661 shares of the business’s stock. A total of $10,230,058 was incurred on buying the stock at an average price of $58.24. A total of 18.48% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $9.22 and a high of $64.84. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.14, and a quick ratio of 1.82.
The net profit margin was 8.15% and return on equity was 26.35% for HIMS. The company reported revenue of $401.56 million for the quarter, compared to $226.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 77.13 percent.
